XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Shares at beginning of period (in shares) at Dec. 31, 2019     72,202         49,277
Beginning of period at Dec. 31, 2019 $ 167,263 $ (214) $ 722 $ 459,545 $ (1,526) $ 350,545 $ (214) $ (642,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 9,106         9,106    
Issuance for stock-based compensation and dividends, net of forfeitures (in shares)     4          
Issuance for stock-based compensation and dividends, net of forfeitures 0     218   (218)    
Stock-based compensation expense 2,896     2,896        
Employee stock purchase plan (in shares)               (4)
Employee stock purchase plan 142     93       $ 49
Dividends (4,293)         (4,293)    
Change in fair value of interest rate swaps (1,121)       (1,121)      
Repurchases of common stock (in shares)               685
Repurchases of common stock (20,380)             $ (20,380)
Shares at end of period (in shares) at Mar. 31, 2020     72,198         49,958
End of period at Mar. 31, 2020 153,399   $ 722 462,752 (2,647) 354,926   $ (662,354)
Shares at beginning of period (in shares) at Dec. 31, 2019     72,202         49,277
Beginning of period at Dec. 31, 2019 167,263 $ (214) $ 722 459,545 (1,526) 350,545 $ (214) $ (642,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 18,991              
Employee stock purchase plan 276              
Defined benefit pension plans 0              
Change in fair value of interest rate swaps (1,591)              
Shares at end of period (in shares) at Jun. 30, 2020     72,237         50,295
End of period at Jun. 30, 2020 152,476   $ 722 465,957 (3,117) 360,409   $ (671,495)
Shares at beginning of period (in shares) at Mar. 31, 2020     72,198         49,958
Beginning of period at Mar. 31, 2020 153,399   $ 722 462,752 (2,647) 354,926   $ (662,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 9,885         9,885    
Issuance for stock-based compensation and dividends, net of forfeitures (in shares)     39          
Issuance for stock-based compensation and dividends, net of forfeitures 0     240   (240)    
Stock-based compensation expense 2,903     2,903        
Employee stock purchase plan (in shares)               (5)
Employee stock purchase plan 134     62       $ 72
Dividends (4,162)         (4,162)    
Defined benefit pension plans 0              
Change in fair value of interest rate swaps (470)       (470)      
Repurchases of common stock (in shares)               342
Repurchases of common stock (9,213)             $ (9,213)
Shares at end of period (in shares) at Jun. 30, 2020     72,237         50,295
End of period at Jun. 30, 2020 152,476   $ 722 465,957 (3,117) 360,409   $ (671,495)
Shares at beginning of period (in shares) at Dec. 31, 2020     72,600         50,427
Beginning of period at Dec. 31, 2020 179,935   $ 726 472,378 (4,423) 388,645   $ (677,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 13,261         13,261    
Issuance for stock-based compensation and dividends, net of forfeitures (in shares)     15          
Issuance for stock-based compensation and dividends, net of forfeitures 0     271   (271)    
Stock-based compensation expense 3,403     3,403        
Employee stock purchase plan (in shares)               (4)
Employee stock purchase plan 170     113       $ 57
Dividends (4,786)         (4,786)    
Defined benefit pension plans 47       47      
Change in fair value of interest rate swaps 939       939      
Repurchases of common stock (in shares)               317
Repurchases of common stock (16,313)             $ (16,313)
Shares at end of period (in shares) at Mar. 31, 2021     72,615         50,740
End of period at Mar. 31, 2021 176,656   $ 726 476,165 (3,437) 396,849   $ (693,647)
Shares at beginning of period (in shares) at Dec. 31, 2020     72,600         50,427
Beginning of period at Dec. 31, 2020 179,935   $ 726 472,378 (4,423) 388,645   $ (677,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 34,449              
Employee stock purchase plan 365              
Defined benefit pension plans 3,103              
Change in fair value of interest rate swaps 949              
Shares at end of period (in shares) at Jun. 30, 2021     72,655         50,961
End of period at Jun. 30, 2021 186,279   $ 727 480,114 (371) 413,018   $ (707,209)
Shares at beginning of period (in shares) at Mar. 31, 2021     72,615         50,740
Beginning of period at Mar. 31, 2021 176,656   $ 726 476,165 (3,437) 396,849   $ (693,647)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 21,188         21,188    
Issuance for stock-based compensation and dividends, net of forfeitures (in shares)     40          
Issuance for stock-based compensation and dividends, net of forfeitures 2     274   (273)    
Stock-based compensation expense 3,532     3,532        
Employee stock purchase plan (in shares)               (4)
Employee stock purchase plan 195     143       $ 52
Dividends (4,746)         (4,746)    
Defined benefit pension plans 3,056       3,056      
Change in fair value of interest rate swaps 10       10      
Repurchases of common stock (in shares)               225
Repurchases of common stock (13,614)             $ (13,614)
Shares at end of period (in shares) at Jun. 30, 2021     72,655         50,961
End of period at Jun. 30, 2021 $ 186,279   $ 727 $ 480,114 $ (371) $ 413,018   $ (707,209)